Cargando…
Organic Anion Transporter Polypeptide 1B1 Polymorphism Modulates the Extent of Drug–Drug Interaction and Associated Biomarker Levels in Healthy Volunteers
Understanding transporter‐mediated drug–drug interactions is an integral part of risk assessment in drug development. Recent studies support the use of hexadecanedioate (HDA), tetradecanedioate (TDA), coproporphyrin (CP)‐I, and CP‐III as clinical biomarkers for evaluating organic anion‐transporting...
Autores principales: | Yee, Sook Wah, Giacomini, Marilyn M., Shen, Hong, Humphreys, W. Griffith, Horng, Howard, Brian, William, Lai, Yurong, Kroetz, Deanna L., Giacomini, Kathleen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662551/ https://www.ncbi.nlm.nih.gov/pubmed/30982223 http://dx.doi.org/10.1111/cts.12625 |
Ejemplares similares
-
Discovery of Regulatory Elements in Human ATP-Binding Cassette Transporters through Expression Quantitative Trait Mapping
por: Matsson, Pär, et al.
Publicado: (2011) -
New and Emerging Research on Solute Carrier and ATP Binding Cassette Transporters in Drug Discovery and Development: Outlook From the International Transporter Consortium
por: Giacomini, Kathleen M., et al.
Publicado: (2022) -
Classification of Inhibitors
of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence
of Protein Expression on Drug–Drug Interactions
por: Karlgren, Maria, et al.
Publicado: (2012) -
Drugs in COVID‐19 Clinical Trials: Predicting Transporter‐Mediated Drug‐Drug Interactions Using In Vitro Assays and Real‐World Data
por: Yee, Sook Wah, et al.
Publicado: (2021) -
The Effects of Genetic Mutations and Drugs on the Activity of the Thiamine Transporter, SLC19A2
por: Enogieru, Osatohanmwen J., et al.
Publicado: (2021)